Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis von Jacober, Sarah Lena Susanna, Disanto, Giulio, Sacco, Rosaria, Meng, Delania, Mallucci, Giulia, Candrian, Ursula, Semini, Sebastiano, Tiberti, Massimiliano, Gobbi, Claudio, Zecca, Chiara

Volltext

Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study von Zecca, Chiara, Merlini, Arianna, Disanto, Giulio, Rodegher, Mariaemma, Panicari, Letizia, Romeo, Marzia Anita Lucia, Candrian, Ursula, Messina, Maria Josè, Pravatà, Emanuele, Moiola, Lucia, Stefanin, Catia, Ghezzi, Angelo, Perrone, Patrizia, Patti, Francesco, Comi, Giancarlo, Gobbi, Claudio, Martinelli, Vittorio

Volltext

A randomized pilot trial of oral prednisone taper vs placebo following iv methylprednisolone for multiple sclerosis relapses: Effects on adrenal function and clinical efficacy von Zecca, Chiara, Disanto, Giulio, Riccitelli, Gianna C., Candrian, Ursula, Deandrea, Maurilio, Limone, Paolo Piero, Sacco, Rosaria, Gobbi, Claudio

Volltext

Treatment Satisfaction, Adherence and Behavioural Assessment in Patients De-escalating from Natalizumab To Interferon Beta (P7.235) von Gobbi, Claudio, Riccitelli, Gianna, Calabrese, Pasquale, Pravatà, Emanuele, Candrian, Ursula, Guttmann, Charles, Zecca, Chiara

Volltext

Treatment satisfaction, adherence and behavioral assessment in patients de-escalating from natalizumab to interferon β von Zecca, Chiara, Riccitelli, Gianna C, Calabrese, Pasquale, Pravatà, Emanuele, Candrian, Ursula, Guttmann, Charles R G, Gobbi, Claudio

Volltext

Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta von Zecca, Chiara, Riccitelli, Gianna C, Calabrese, Pasquale, Pravatà, Emanuele, Candrian, Ursula, Guttmann, Charles RG, Gobbi, Claudio

Volltext